Literature DB >> 14741840

Bio-Alcamid in drug-induced lipodystrophy.

Carmelo Protopapa1, Giuseppe Sito, Domenico Caporale, Nazzareno Cammarota.   

Abstract

The development of new drugs to counter human immunodeficiency virus (HIV) infection has led to an increase in lipodystrophic syndrome among HIV-infected individuals receiving combination therapy. Bio-Alcamid(TM) is a recently developed polymeric substance that can be implanted to compensate for adipose effects. We have implanted this substance in 73 patients with up to three years' follow-up. The aesthetic results were deemed excellent by both physicians and patients. No implant dislocation, implant migration, granuloma, allergic reaction or intolerance were recorded.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14741840     DOI: 10.1080/14764170310021922

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  4 in total

Review 1.  Plastic surgical approaches for HIV-associated lipoatrophy.

Authors:  Graeme J Moyle
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

2.  Experimental vitreous tamponade using polyalkylimide hydrogel.

Authors:  Sven Crafoord; Sten Andreasson; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-31       Impact factor: 3.117

3.  A new model for in vitro testing of vitreous substitute candidates.

Authors:  Henrik Barth; Sven Crafoord; Timothy M O'Shea; Christopher D Pritchard; Robert Langer; Fredrik Ghosh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-25       Impact factor: 3.117

4.  Long-term outcomes of surgically removed migrated polyalkylimide (bio-alcamid) filler to the periorbital area.

Authors:  Ziyad A AlHarbi; Hind M Alkatan; Adel H Alsuhaibani
Journal:  Saudi J Ophthalmol       Date:  2019-07-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.